The State Health Department Secretary publicly announced on Thursday that patients diagnosed with anxiety disorders and/or Tourette’s syndrome will be eligible to receive recommendations to legally access medical cannabis products. The new rules take effect on July 20.
Inhaled cannabis is effective and well-tolerated in patients with Tourette’s Syndrome, according to clinical data published online ahead of print in the Journal of Neuropsychiatry and Clinical Neuroscience. They concluded: “Overall, these study participants experienced substantial improvements in their symptoms. This is particularly striking given that almost all participants had failed at least one anti-tic medication trial.
[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
May 25, 2012 Dear NORML supporters in AZ, Good news! The Arizona Department of Health…
Union-Tribune’s Newsroom Operations Manager (in reference to their coverage below), she pledges: “I will follow up with our online staff right now. We will get it corrected or taken down.” Yet, as of 11am pst today the story still appears online in its original form. Those who live in southern California may also wish to voice their opinion at: http://www.signonsandiego.com/contactus/.
For anyone who missed the worldwide corporate media’s hysterical anti-pot headlines last week, here’s a sampling:
First it was Marie Claire magazine with their “Stiletto Stoners”, followed by a sympathetic follow-up on the NBC Today Show. Now Elle Magazine prints 2,758 words from another Stiletto Stoner who has discovered that cannabis is a superior medication for her generalized anxiety disorder than the Zoloft and Paxil her doctors had recommended.